AGILON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Investors in Agilon Health, Inc. to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Agilon Health, Inc. for possible violations of federal securities laws following significant leadership changes and financial disclosures that negatively impacted the company's stock price [1][2]. Investigation Details - On August 4, 2025, Agilon Health announced the resignation of its President and CEO, Steven Sell, and released its second-quarter 2025 financial results, withdrawing its full-year 2025 earnings guidance, leading to a more than 27% drop in share price during after-hours trading [2]. - The investigation is centered on whether Agilon failed to disclose material information regarding the leadership transition and guidance withdrawal, which may constitute a violation of federal securities laws [2]. Next Steps - Investors who purchased Agilon shares and experienced losses are encouraged to contact Bragar Eagel & Squire for more information about their rights and potential claims [3].